On the working visit of the Special Representative of the President of the Russian Federation for the Middle East and Africa, Deputy Minister of Foreign Affairs of Russia H.E. Mikhail BOGDANOV to the Republic of Guinea
During the talks, a detailed discussion of topical issues and further progressive development of the entire complex of traditionally friendly Russian-Guinean relations took place. The intention of Moscow and Conakry to deepen a trust-based political dialogue, build up trade, economic, investment and humanitarian ties in line with the agreements reached at the highest level was confirmed. A solid potential for expanding mutually beneficial partnership through the implementation of promising joint projects in the fields of geological exploration and development of mineral deposits, infrastructure, energy, transport, fishing, and agriculture was highlighted. In this context, the importance of holding a regular meeting of the Intergovernmental Russian-Guinean Commission on Economic, Scientific, Technical and Trade Cooperation this year, considering the ongoing preparations for the second Russia-Africa summit in 2022 was stressed.
From the same and consonant positions of Moscow and Conakry, a number of international and African topics of mutual interest were discussed, including the tasks of countering terrorism and extremism in the Sahara-Sahel region and in West Africa, combating piracy in the Gulf of Guinea, resolving crises in Libya, Mali, the Central African Republic, and other "hot points" on the African continent. In general, Parties confirmed their commitment to close coordination of Russia's and Guinea's steps in the UN and other multilateral organizations.
Another batch of the Sputnik V vaccine as well as and PCR diagnostic test systems and other medical supplies were delivered to Conakry. The Guinean side expressed its deep gratitude to Russia for its continued effective assistance in the fight against dangerous infectious diseases, including through the supply to Guinea of medical equipment and drugs for the treatment and diagnosis of COVID-19.